| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CERO | Common Stock | Sale | $148,425 | -1,236,874 | -5.5% | $0.1200 | 21,383,909 | 06 Dec 2024 | By YK Bioventures Opportunities Fund I, L.P. | F1 |
| transaction | CERO | Common Stock | Sale | $93,560 | -850,543 | -4% | $0.1100 | 20,533,366 | 09 Dec 2024 | By YK Bioventures Opportunities Fund I, L.P. | F1 |
| transaction | CERO | Common Stock | Sale | $141,385 | -1,570,947 | -7.7% | $0.0900 | 18,962,419 | 10 Dec 2024 | By YK Bioventures Opportunities Fund I, L.P. | F1 |
| Id | Content |
|---|---|
| F1 | Securities are held directly by YK Bioventures Opportunities Fund I, L.P. (f/k/a YK Bioventures, LLC) ("YK Opps I"). YK Bioventures Opportunities GP I, LLC ("YK Opps I GP") is the general partner of YK Opps I and may be deemed to beneficially own the shares held by YK Opps I. Mitchell W. Kossar and Gary K. Yeung are managing partners of YK Opps I GP, and may be deemed to share voting and investment power over the shares held by YK Opps I. Each of YK Opps I GP and Messrs. Kossar and Yeung disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. |